Adrabetadex to Treat Niemann-Pick Type C1 (NPC1) Disease

Clinical trial NCT04958642 · TERMINATED

Trial details

NCT number: NCT04958642
Sponsor: Mandos LLC
Status: TERMINATED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Niemann-Pick Disease, Type C

Start date: 2015-12-23
Primary completion: 2022-04-11
Enrollment: 66

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.